Eagle LogoPEPTIDE INITIATIVE

Peptide Database

Goals
Fat LossMuscle BuildingInjury HealingAnti-AgingCognitive EnhancementSleep OptimizationImmune SupportGut HealingSkin RejuvenationSexual Health
Peptides
Adipotide
Weight Management
AOD-9604
Weight Management
BPC-157
Healing & Recovery
Cagrilintide
Weight Management
CJC-1295
Growth Hormone
DSIP
Sleep & Recovery
Epithalon
Anti-Aging
GHK-Cu
Anti-Aging
GHRP-2
Growth Hormone
HCG
Hormone Support
Hexarelin
Growth Hormone
HGH
Growth Hormone
IGF-1 LR3
Growth Hormone
Kisspeptin
Hormone Support
Melanotan-2
Cosmetic
MOTS-C
Metabolic
NAD+
Anti-Aging
Oxytocin Acetate
Hormone Support
PEG-MGF
Recovery
PNC-27
Cancer Research
PT-141
Sexual Health
Retatrutide
Weight Management
Selank
Cognitive
Semaglutide
Weight Management
Semax
Cognitive
Sermorelin
Growth Hormone
Snap-8
Cosmetic
SS-31
Mitochondrial
TB-500
Healing & Recovery
Tesamorelin
Growth Hormone
Thymosin Alpha-1
Immune
Tirzepatide
Weight Management
Total Peptides: 32
Back to Home

Peptide Comparison

CapromorelinvsCJC-1295 (No DAC)

An oral ghrelin agonist originally developed by Pfizer that stimulates growth hormone and appetite. FDA-approved for veterinary use (Entyce and Elura) and investigated in human trials for age-related muscle wasting and appetite support.

A modified growth hormone-releasing hormone that boosts your body's natural GH pulses for better recovery, deeper sleep, and improved body composition.

Growth HormoneGrowth Hormone

At a Glance

Quick
comparison

Dose Range

Capromorelin

3–30 mg

CJC-1295 (No DAC)

100–300 mcg

Frequency

Capromorelin

Once daily

CJC-1295 (No DAC)

Once daily

Administration

Capromorelin

Oral (capsule or tablet)

CJC-1295 (No DAC)

Subcutaneous injection

Cycle Length

Capromorelin

4-6 weeks

CJC-1295 (No DAC)

8-12 weeks

Onset Speed

Capromorelin

Moderate (1-2 weeks)

CJC-1295 (No DAC)

Moderate (1-2 weeks)

Evidence Level

Capromorelin

Moderate human trials (Phase 1-2)

CJC-1295 (No DAC)

Moderate human trials (Phase 1-2)

Efficacy

Benefit
ratings

Capromorelin
CJC-1295 (No DAC)

GH & IGF-1 Stimulation

Capromorelin88%
CJC-1295 (No DAC)0%

Physical Function

Capromorelin82%
CJC-1295 (No DAC)0%

Oral Convenience

Capromorelin92%
CJC-1295 (No DAC)0%

GH Stimulation

Capromorelin0%
CJC-1295 (No DAC)88%

Sleep Quality

Capromorelin0%
CJC-1295 (No DAC)92%

Recovery Support

Capromorelin0%
CJC-1295 (No DAC)85%

Technical Data

Compound
specifications

Capromorelin

Molecular Formula

C28H35N5O4

Molecular Weight

505.6 g/mol

Half-Life

1-2.4 hours in humans

Bioavailability

Good oral bioavailability

CAS Number

193273-66-4

CJC-1295 (No DAC)

Molecular Formula

C152H252N44O42

Molecular Weight

3367.9 g/mol

Half-Life

30 minutes to 2 hours

Bioavailability

~100% (subcutaneous)

CAS Number

863288-34-0

Protocols

Dosing
tiers

Capromorelin

CJC-1295 (No DAC)

starting

100 mcg

Once daily before bed

2-4 weeks

Start here to assess tolerance and response. Best taken before bed to align with natural GH release during sleep.

standard

100-150 mcg

1-2 times daily

8-12 weeks

Most effective protocol for general health benefits. Often combined with a GHRP like Ipamorelin for enhanced effects.

advanced

150-300 mcg

2-3 times daily

8-12 weeks

Higher dosing for experienced users seeking maximum GH stimulation. Always combined with a GHRP for synergistic effects.

Applications

Best
suited for

Capromorelin

Age-Related Muscle Wasting

Capromorelin showed significant improvements in physical function — including tandem walk and stair climb — in elderly adults, making it a strong candidate for combating sarcopenia.

Appetite Stimulation

As an FDA-approved veterinary appetite stimulant, capromorelin has extensive real-world evidence for boosting food intake and body weight in mammals.

Growth Hormone Research

One of the best-studied oral ghrelin agonists with human Phase 2 data, offering researchers a well-characterized tool for studying GH/IGF-1 pathways.

CJC-1295 (No DAC)

Natural Growth Hormone Optimization

Perfect for those wanting to boost their body's own GH production rather than using synthetic growth hormone. Mimics the natural pulsatile release pattern your pituitary uses.

Workout Recovery and Muscle Building

Athletes and fitness enthusiasts use it to accelerate recovery between training sessions, support lean muscle development, and reduce body fat over time.

Sleep Quality Enhancement

Because GH is naturally released during deep sleep, many users report dramatically improved sleep quality with more vivid dreams and feeling more refreshed upon waking.

Anti-Aging and Vitality

As GH levels decline with age, CJC-1295 helps restore more youthful hormone patterns, potentially improving skin quality, energy levels, and overall well-being.

Synergistic Peptide Stacking

Designed to work hand-in-hand with GHRPs like Ipamorelin. When combined, these peptides amplify each other's effects for significantly greater GH release than either alone.

Safety Profile

Side
effects

Capromorelin

Common

  • Appetite stimulation
  • Fluid retention and weight gain

Uncommon

  • Joint and muscle aches
  • Fatigue or lethargy
  • Peripheral edema (swelling)

Serious

  • Hyperglycemia

CJC-1295 (No DAC)

Common

  • Injection site reactions
  • Flushing or warmth
  • Water retention
  • Increased appetite

Uncommon

  • Tingling or numbness
  • Headache

Serious

  • Allergic reaction

Research Status

Safety
& evidence

Capromorelin

Evidence Level

Moderate human trials (Phase 1-2)

FDA Status

FDA approved for this use

Safety Overview

Capromorelin was generally well-tolerated in Phase 2 human trials involving nearly 400 elderly participants. Most side effects were mild to moderate. Its FDA-approved veterinary use provides additional long-term safety data in mammalian species.

Contraindications

  • xActive cancer or history of cancer (GH may stimulate growth)
  • xUncontrolled diabetes or severe metabolic disorders
  • xSevere liver or kidney disease
  • xPregnancy and lactation

CJC-1295 (No DAC)

Evidence Level

Moderate human trials (Phase 1-2)

FDA Status

Research compound

Safety Overview

CJC-1295 without DAC has been studied in Phase 1-2 human clinical trials with a favorable safety profile. The most common side effects are mild and include injection site reactions and temporary flushing. Because it stimulates natural GH release rather than providing exogenous GH, it maintains the body's feedback mechanisms.

Contraindications

  • xActive cancer or history of cancer
  • xPregnancy or breastfeeding
  • xPituitary tumors or disorders
  • xHypersensitivity to GHRH analogs
  • xDiabetic retinopathy

Decision Guide

Which is
right for you?

Choose Capromorelin if...

  • Stimulating growth hormone production in elderly adults
  • Supporting appetite and weight gain in wasting conditions
  • Improving muscle mass and physical performance
  • Anti-aging and longevity optimization

Choose CJC-1295 (No DAC) if...

  • Increasing natural growth hormone levels
  • Building lean muscle mass
  • Improving sleep quality
  • Enhancing workout recovery